AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 68 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $42,000 | -26.3% | 67,500 | 0.0% | 0.00% | – |
| Q3 2019 | $57,000 | -70.8% | 67,500 | -76.7% | 0.00% | – |
| Q2 2019 | $195,000 | +143.8% | 289,856 | +196.4% | 0.00% | – |
| Q1 2019 | $80,000 | -92.8% | 97,789 | -86.0% | 0.00% | -100.0% |
| Q4 2018 | $1,116,000 | -43.1% | 697,500 | +17.7% | 0.00% | 0.0% |
| Q3 2018 | $1,961,000 | +1385.6% | 592,442 | +913.4% | 0.00% | – |
| Q2 2018 | $132,000 | -88.5% | 58,459 | -85.2% | 0.00% | -100.0% |
| Q1 2018 | $1,149,000 | +34.9% | 396,202 | +29.7% | 0.00% | 0.0% |
| Q4 2017 | $852,000 | -27.0% | 305,481 | -4.5% | 0.00% | 0.0% |
| Q3 2017 | $1,167,000 | – | 319,900 | +615092.3% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 52 | -99.9% | 0.00% | – |
| Q2 2014 | $86,000 | +4200.0% | 86,325 | +3832.8% | 0.00% | – |
| Q1 2014 | $2,000 | +100.0% | 2,195 | +67.7% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 1,309 | +153.2% | 0.00% | – |
| Q3 2013 | $1,000 | -96.0% | 517 | -94.7% | 0.00% | – |
| Q2 2013 | $25,000 | – | 9,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
| New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
| RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
| NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
| Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
| 683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
| Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
| EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
| Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |